Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Treasury Shares (2025 - 2026)

Kura Oncology has reported Treasury Shares over the past 2 years, most recently at $436667.0 for Q1 2026.

  • Quarterly Treasury Shares changed N/A to $436667.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $436667.0 through Mar 2026, changed N/A year-over-year, with the annual reading at $436667.0 for FY2025, N/A changed from the prior year.
  • Treasury Shares was $436667.0 for Q1 2026 at Kura Oncology, roughly flat from $436667.0 in the prior quarter.
  • Over five years, Treasury Shares peaked at $775534.0 in Q3 2025 and troughed at $436667.0 in Q4 2025.